Oxolinic acid


Generic Medicine Info
Indications and Dosage
Oral
Urinary tract infections
Adult: 750 mg every 12 hr.
Contraindications
Hypersensitivity. Severe renal impairment. Pregnancy and lactation. G6PD deficiency. Children. Convulsive conditions.
Special Precautions
Impaired renal or hepatic function; exposure to strong sunlight. Elderly.
Adverse Reactions
Urinary stones, muscle pain, hypersensivity reactions (e.g. rash, urticaria, pruritus, photosensitivity, leukopenia, eosinophilia), nausea, vomiting, anorexia, epigastric pain, abdominal pain, diarrhoea, metallic taste, increased LFTs, insomnia, anxiety, nervousness, confusion, vertigo, somnolence, headache, peripheral neuropathy, paraesthesia, photophobia, blurred vision, disturbances in accommodation, diplopia, convulsions, hallucination.
Action
Description: Oxolinic acid is a quinolone antibacterial agent with properties similar to nalidixic acid. It interferes with bacterial DNA replication probably by inactivating bacterial DNA gyrase (type II topoisomerase).
Pharmacokinetics:
Absorption: Absorbed in the GI tract. Peak plasma concentration in 30-60 min.
Distribution: Protein-binding: 80%.
Metabolism: Hepatic.
Excretion: Via urine. Half-life: 4-6 hr.
MIMS Class
Quinolones
Disclaimer: This information is independently developed by MIMS based on Oxolinic acid from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2024 MIMS. All rights reserved. Powered by MIMS.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in